BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25898925)

  • 1. Leveraging ancestry to improve causal variant identification in exome sequencing for monogenic disorders.
    Brown R; Lee H; Eskin A; Kichaev G; Lohmueller KE; Reversade B; Nelson SF; Pasaniuc B
    Eur J Hum Genet; 2016 Jan; 24(1):113-9. PubMed ID: 25898925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An automatic and efficient pipeline for disease gene identification through utilizing family-based sequencing data.
    Song D; Li N; Liao L
    Biomed Mater Eng; 2015; 26 Suppl 1():S1797-803. PubMed ID: 26405949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. exomeSuite: Whole exome sequence variant filtering tool for rapid identification of putative disease causing SNVs/indels.
    Maranhao B; Biswas P; Duncan JL; Branham KE; Silva GA; Naeem MA; Khan SN; Riazuddin S; Hejtmancik JF; Heckenlively JR; Riazuddin SA; Lee PL; Ayyagari R
    Genomics; 2014; 103(2-3):169-76. PubMed ID: 24603341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-Informed Gene Ranking Tackles Genetic Heterogeneity in Exome-Sequencing Studies of Monogenic Disease.
    Dand N; Schulz R; Weale ME; Southgate L; Oakey RJ; Simpson MA; Schlitt T
    Hum Mutat; 2015 Dec; 36(12):1135-44. PubMed ID: 26394720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritization Of Nonsynonymous Single Nucleotide Variants For Exome Sequencing Studies Via Integrative Learning On Multiple Genomic Data.
    Wu M; Wu J; Chen T; Jiang R
    Sci Rep; 2015 Oct; 5():14955. PubMed ID: 26459872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational and statistical approaches to analyzing variants identified by exome sequencing.
    Stitziel NO; Kiezun A; Sunyaev S
    Genome Biol; 2011 Sep; 12(9):227. PubMed ID: 21920052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. wKGGSeq: A Comprehensive Strategy-Based and Disease-Targeted Online Framework to Facilitate Exome Sequencing Studies of Inherited Disorders.
    Li MJ; Deng J; Wang P; Yang W; Ho SL; Sham PC; Wang J; Li M
    Hum Mutat; 2015 May; 36(5):496-503. PubMed ID: 25676918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Disease Susceptibility Alleles in the Next Generation Sequencing Era.
    DiStefano JK; Kingsley CB
    Methods Mol Biol; 2018; 1706():3-16. PubMed ID: 29423790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders.
    Mutarelli M; Marwah V; Rispoli R; Carrella D; Dharmalingam G; Oliva G; di Bernardo D
    BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S5. PubMed ID: 25078076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Sequencing for Diagnosing Rare Diseases.
    Wojcik MH; Lemire G; Berger E; Zaki MS; Wissmann M; Win W; White SM; Weisburd B; Wieczorek D; Waddell LB; Verboon JM; VanNoy GE; Töpf A; Tan TY; Syrbe S; Strehlow V; Straub V; Stenton SL; Snow H; Singer-Berk M; Silver J; Shril S; Seaby EG; Schneider R; Sankaran VG; Sanchis-Juan A; Russell KA; Reinson K; Ravenscroft G; Radtke M; Popp D; Polster T; Platzer K; Pierce EA; Place EM; Pajusalu S; Pais L; Õunap K; Osei-Owusu I; Opperman H; Okur V; Oja KT; O'Leary M; O'Heir E; Morel CF; Merkenschlager A; Marchant RG; Mangilog BE; Madden JA; MacArthur D; Lovgren A; Lerner-Ellis JP; Lin J; Laing N; Hildebrandt F; Hentschel J; Groopman E; Goodrich J; Gleeson JG; Ghaoui R; Genetti CA; Gburek-Augustat J; Gazda HT; Ganesh VS; Ganapathi M; Gallacher L; Fu JM; Evangelista E; England E; Donkervoort S; DiTroia S; Cooper ST; Chung WK; Christodoulou J; Chao KR; Cato LD; Bujakowska KM; Bryen SJ; Brand H; Bönnemann CG; Beggs AH; Baxter SM; Bartolomaeus T; Agrawal PB; Talkowski M; Austin-Tse C; Abou Jamra R; Rehm HL; O'Donnell-Luria A
    N Engl J Med; 2024 Jun; 390(21):1985-1997. PubMed ID: 38838312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing in suspected monogenic dyslipidemias.
    Stitziel NO; Peloso GM; Abifadel M; Cefalu AB; Fouchier S; Motazacker MM; Tada H; Larach DB; Awan Z; Haller JF; Pullinger CR; Varret M; Rabès JP; Noto D; Tarugi P; Kawashiri MA; Nohara A; Yamagishi M; Risman M; Deo R; Ruel I; Shendure J; Nickerson DA; Wilson JG; Rich SS; Gupta N; Farlow DN; Neale BM; Daly MJ; Kane JP; Freeman MW; Genest J; Rader DJ; Mabuchi H; Kastelein JJ; Hovingh GK; Averna MR; Gabriel S; Boileau C; Kathiresan S
    Circ Cardiovasc Genet; 2015 Apr; 8(2):343-50. PubMed ID: 25632026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Detection of Rare Deleterious Variants by Next Generation Sequencing with Optional Microarray SNP Genotype Data.
    Watson CM; Crinnion LA; Gurgel-Gianetti J; Harrison SM; Daly C; Antanavicuite A; Lascelles C; Markham AF; Pena SD; Bonthron DT; Carr IM
    Hum Mutat; 2015 Sep; 36(9):823-30. PubMed ID: 26037133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.
    Rabbani B; Mahdieh N; Hosomichi K; Nakaoka H; Inoue I
    J Hum Genet; 2012 Oct; 57(10):621-32. PubMed ID: 22832387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblings.
    Gu F; Wu A; Gordon MG; Vlahos L; Macnamara S; Burke E; Malicdan MC; Adams DR; Tifft CJ; Toro C; Gahl WA; Markello TC
    Genet Med; 2019 Aug; 21(8):1772-1780. PubMed ID: 30700791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global inference of disease-causing single nucleotide variants from exome sequencing data.
    Wu M; Chen T; Jiang R
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):468. PubMed ID: 28155632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort.
    Gambin T; Akdemir ZC; Yuan B; Gu S; Chiang T; Carvalho CMB; Shaw C; Jhangiani S; Boone PM; Eldomery MK; Karaca E; Bayram Y; Stray-Pedersen A; Muzny D; Charng WL; Bahrambeigi V; Belmont JW; Boerwinkle E; Beaudet AL; Gibbs RA; Lupski JR
    Nucleic Acids Res; 2017 Feb; 45(4):1633-1648. PubMed ID: 27980096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in exome analysis by LifeScope and its alternative computational pipelines.
    Pranckevičiene E; Rančelis T; Pranculis A; Kučinskas V
    BMC Res Notes; 2015 Sep; 8():421. PubMed ID: 26346699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.